MarketHealth CareHealth Care Equipment & SuppliesHealth Care Equipment
NEXALIN TECHNOLOGY I

NXL

$0.43Sep 16, 2022Apr 24, 2026
Health CareHealth Care Equipment & SuppliesHealth Care Equipment$7M
MVM
-$0.1M
TD Variance
-0.939

Every news event mapped to its market reaction — 91 events, 44 months of data. No predictions, just what happened.

PositiveNegativeNo data· Dot size = magnitude · Scroll to zoom · Drag to pan
Hover to inspect

Want the full written briefing?

The chart shows what moved — the briefing shows why. Sourced, dated, no hot takes.

Subscribe on Substack →

News Events

DateReturnCategorySourceHeadline
2025-10-08+59.6%newsStock Titan40‑Hz 15mA DIFS improves cognition: Nexalin's Gen‑2 SYNC shows fMRI connectivity gains in mild AD - Stock Titan
2025-10-08+59.6%newsStocksToTradeIs Nexalin’s Stock Set to Skyrocket? - StocksToTrade
2025-10-08+59.6%newsStocksToTradeNexalin Technology Inc. (NXL) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
2025-10-08+59.6%newsInvesting.com South AfricaNexalin stock soars after Alzheimer’s treatment shows cognitive benefits By Investing.com - Investing.com South Africa
2024-06-18+45.7%legalSEC EDGARNXL 8-K: 8.01 and (SEC Filing)
2024-06-28-43.7%newsSeeking AlphaNexalin Technology stock slides on pricing stock offering to raise $5.2 million
2024-06-28-43.7%legalSEC EDGARNXL 8-K: 1.01, 8.01 (SEC Filing)
2024-04-16-32.6%newsSeeking AlphaNexalin Technology files to offer common stock worth $5.65M
2025-05-05-28.2%newsSeeking AlphaNexalin Technology slides after pricing $5M stock offering
2025-05-05-28.2%legalSEC EDGARNXL 8-K: 1.01 and (SEC Filing)
2022-09-18-25.7%analystZacks Investment ResearchWhat is the current Price Target and Forecast for Nexalin Technology, Inc. (NXL) - Zacks Investment Research
2022-09-18-25.7%newsZacks Investment ResearchShould I buy Nexalin Technology, Inc. (NXL) - Zacks Investment Research
2025-07-21+16.3%legalSEC EDGARNXL 8-K: 5.02 and (SEC Filing)
2026-04-14+16.1%newsGlobeNewswireJoin Nexalin’s Exclusive Live Investor Webinar and Q&A Session on April 21
2026-04-14+16.1%executiveStock TitanNexalin CEO to outline mental health device strategy April 21 - Stock Titan
2024-07-03-15.6%legalSEC EDGARNXL 8-K: 1.01, 8.01 (SEC Filing)
2026-04-09+14.3%newsGlobeNewswireNexalin Announces Peer-Reviewed Study Showing the Company’s DIFS™ Technology Reduced Self-Injury and Depression Symptoms in Female Adolescents
2026-04-09+14.3%newsStock TitanNexalin teen pilot finds noninvasive brain stimulation cut self-harm - Stock Titan
2022-09-20-14.3%legalSEC EDGARNXL 8-K: 1.01, 8.01 (SEC Filing)
2026-02-23+13.6%newsStock TitanCongress boosts brain stimulation research for veterans, with Nexalin involved - Stock Titan
2026-04-10+12.5%newsCổng thông tin điện tử Tỉnh Sơn LaAre investors bearish on Nexalin Technology (NXL) Stock | Price at $0.39, Up 1.32% - Trending Momentum Stocks - Cổng thông tin điện tử Tỉnh Sơn La
2024-11-10-12.2%newsYahoo FinanceIs Nexalin Technology (NASDAQ:NXL) In A Good Position To Invest In Growth? - Yahoo Finance
2024-04-26+10.6%legalSEC EDGARNXL 8-K: 8.01 and (SEC Filing)
2026-04-16-10.5%newsSimply Wall St.ASX Stocks That May Be Trading Below Their Estimated Value
2026-02-05-10.0%expansionInvesting.comNexalin Technology stock rises after launching AI-powered virtual clinic - Investing.com
2026-02-05-10.0%newsStock TitanHome-based brain therapy: Nexalin, UCSD roll out AI virtual clinic - Stock Titan
2026-04-23-9.7%earningsCổng thông tin điện tử tỉnh Tây NinhNXL (Nexalin Technology Inc.) reports narrow Q4 2025 EPS miss, shares rise 18 percent on positive investor sentiment. - Binary Event - Cổng thông tin điện tử tỉnh Tây Ninh
2022-09-22-9.6%earningsMarketBeatNexalin Technology (NXL) Stock Price, News & Analysis $NXL - MarketBeat
2022-09-22-9.6%earningsMarketBeatNexalin Technology (NXL) Earnings Date and Reports 2026 $NXL - MarketBeat
2025-10-10-9.5%newsYahoo FinanceIs Nexalin Technology (NASDAQ:NXL) In A Good Position To Deliver On Growth Plans? - Yahoo Finance
2025-09-22+9.2%legalSEC EDGARNXL 8-K: 8.01 and (SEC Filing)
2024-11-01+8.6%legalSEC EDGARNXL 8-K: 8.01 and (SEC Filing)
2025-12-20-8.1%newsTrefisNexalin Technology Stock Drop Looks Sharp, But How Deep Can It Go? - Trefis
2024-05-17-7.8%newsStockInvest.usHistorical NXL stock prices (quote) - Nexalin Technology, Inc. - StockInvest.us
2026-04-15+7.1%legalGlobeNewswireNexalin Advances FDA Alzheimer’s Strategy Following Landmark Leadership Meetings in the U.S. and China
2026-04-15+7.1%legalStock TitanAfter FDA and China meetings, Nexalin reshapes Alzheimer’s study - Stock Titan
2026-04-15+7.1%newsCổng thông tin điện tử tỉnh Tây NinhWhat to Know About Nexalin Technology (NXL) Stock Today (Institutional Demand) 2026-04-15 - Target Price - Cổng thông tin điện tử tỉnh Tây Ninh
2024-04-11-7.0%legalSEC EDGARNXL 8-K: 8.01 and (SEC Filing)
2023-09-28-6.5%legalSEC EDGARNXL 8-K: 5.02 (SEC Filing)
2024-05-19-6.2%earningsMarketBeatNexalin Technology (NXL) Stock Forecast and Price Target 2026 $NXL - MarketBeat
2024-03-14+5.9%newsSeeking AlphaNexalin Technology commences sales of gen-2 neurostimulation device in Oman
2025-05-06-5.6%legalSEC EDGARNXL 8-K: 1.01, 8.01 (SEC Filing)
2022-09-30-5.4%newsChartMillNXL Stock Price, Quote & Chart | NEXALIN TECHNOLOGY INC (NASDAQ:NXL) - ChartMill
2026-01-23-5.1%newsSeeking AlphaNexalin Technology receives Nasdaq bid price deficiency notice
2026-01-23-5.1%legalSEC EDGARNXL 8-K: 3.01, 8.01 (SEC Filing)
2026-01-23-5.1%newsStock TitanNexalin has 180 days to lift Nasdaq share price back to $1 - Stock Titan
2026-04-20-5.0%newsACCESS NewswireRedChip's Biotech Investor Conference Replays Now Available
2026-04-20-5.0%newsCổng thông tin điện tử Tỉnh Sơn LaNexalin Technology (NXL) Stock: Why Growth Investors Chase It (-2.65%) 2026-04-20 - Hedge Fund Inspired Picks - Cổng thông tin điện tử Tỉnh Sơn La
2026-04-20-5.0%newsUBND thành phố Hải PhòngNexalin Technology (NXL) Stock: Why Growth Investors Chase It (-2.65%) 2026-04-20 - High Volume Stocks - UBND thành phố Hải Phòng
2024-07-16-4.8%legalSEC EDGARNXL 8-K: 8.01 (SEC Filing)
2025-05-27-4.7%newsIntellectia AINXL Forecast — Price Prediction for 2026. Should I Buy NXL? - Intellectia AI
2023-04-06+4.5%newsCoinCodexNexalin Technology, Inc. (NXL) Stock Forecast & Price Prediction 2026–2030 - CoinCodex
2025-02-06+4.5%legalSEC EDGARNXL 8-K: 8.01 and (SEC Filing)
2024-07-30-4.5%legalSEC EDGARNXL 8-K: 5.02 (SEC Filing)
2026-04-06+4.0%newsCổng thông tin điện tử tỉnh Lào CaiIs Nexalin Technology (NXL) Stock Good for Beginners | Price at $0.36, Up 2.33% - Crowd Consensus Signals - Cổng thông tin điện tử tỉnh Lào Cai
2024-01-11+4.0%newsStock TitanNexalin Technology Unveils Next-Generation HALO™ Clarity - Stock Titan
2024-09-19+3.6%legalSEC EDGARNXL 8-K: 5.02 and (SEC Filing)
2025-06-09-3.4%legalSEC EDGARNXL 8-K: 8.01 and (SEC Filing)
2025-10-15+3.3%legalSEC EDGARNXL 8-K: 1.01 and (SEC Filing)
2025-10-15+3.3%newsInvesting.comNexalin Technology expands at-the-market offering to $10 million - Investing.com
2025-04-21+2.9%newsStock TitanMedicare May Cover AI Mental Health Devices as Nexalin Backs New Bill | NXL Stock News - Stock Titan
2026-03-29-2.7%newsSimply Wall St.Three High Growth Tech Stocks in Australia
2025-04-23+2.6%newsSeeking AlphaNexalin Technology files $50M common stock offering
2025-08-04+2.1%legalSEC EDGARNXL 8-K: 5.02 and (SEC Filing)
2026-04-03+1.8%newsXã Thanh HàNXL Stock Analysis: Nexalin Technology Inc. sits at $0.35 with mild 0.73% daily dip - Xã Thanh Hà
2026-04-22-1.8%earningsGlobeNewswireNexalin Technology Advances Pivotal Clinical Trial of HALO™ Clarity Toward Q2 2026 Enrollment
2026-04-22-1.8%legalSEC EDGARNXL 8-K: 1.01, 7.01 (SEC Filing)
2026-04-22-1.8%legalStock TitanNexalin lines up 160-patient insomnia study to support FDA filing - Stock Titan
2026-04-22-1.8%earningsXã Thanh HàNXL Nexalin Technology Q4 2025 earnings narrowly miss consensus estimates, shares tick higher as investors overlook minor shortfall. - Stock Analysis Community - Xã Thanh Hà
2026-04-22-1.8%newsStock TitanNexalin (NXL) funds 160-patient pivotal HALO Clarity insomnia trial - Stock Titan
2025-04-24+1.7%newsStock TitanNXL Stock Price, News & Analysis - Stock Titan
2025-05-28-1.5%newsStock TitanRevolutionary Mental Health Tech: Nexalin Unveils Game-Changing Treatment in $537B Market Webinar - Stock Titan
2026-02-24+1.3%earningsGlobeNewswireNexalin Announces Pivotal HALO™ Clarity Trial to Support Planned De Novo FDA Submission Targeting Multi-Billion-Dollar Insomnia Market
2026-02-24+1.3%newsStock TitanDrug-free insomnia device trial targets 30 million adults - Stock Titan
2023-06-02-1.3%legalSEC EDGARNXL 8-K: 1.01 and (SEC Filing)
2023-06-01+1.1%newsSeeking AlphaNexalin Technology, Wider Come Limited formalize JV pact
2026-04-02+0.8%newsACCESS NewswireRedChip Showcases Public Companies Driving Biotech Innovation at April 16 Virtual Investor Conference
2024-04-25+0.8%newsSeeking AlphaNexalin Technology regains compliance with Nasdaq continued listing requirements
2026-04-17-0.8%newsSimply Wall St.April 2026 Global's Top Undervalued Small Caps With Insider Action
2026-04-21+0.5%analystChartMillNXL Forecast, Price Target & Analyst Ratings | NEXALIN TECHNOLOGY INC (NASDAQ:NXL) - ChartMill
2025-08-01-0.5%executiveSeeking AlphaNexalin Technology appoints Justin Fleet as CFO
2025-08-01-0.5%executiveSeeking AlphaNexalin Technology appoints Justin Van Fleet as CFO
2025-04-02-0.4%expansionStock TitanRevolutionary Brain Treatment: Nexalin Launches PTSD Trial at UCSD with AI-Powered Home Therapy - Stock Titan
2024-01-04+0.2%newsCNNsymbol__ Stock Quote Price and Forecast - CNN
2026-04-08+0.1%legalStock TitanNXL SEC Filings - Nexalin Tech 10-K, 10-Q, 8-K Forms - Stock Titan
2025-12-05-0.1%legalSEC EDGARNXL 8-K: 8.01 and (SEC Filing)
2026-04-26newsQuantisnowNexalin Interview to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Quantisnow
2022-09-16newsSeeking AlphaNeurostimulation device maker Nexalin stock drops 51% after $10M IPO (update)
2022-09-16newsSeeking AlphaMedical devices firm Nexalin prices ~$9.6M IPO
2022-09-16legalSEC EDGARNXL 8-K: 1.01, 8.01 (SEC Filing)
2022-09-16newsTradingViewNXL Stock Price and Chart — NASDAQ:NXL - TradingView
tickerdossier.comtickerdossier.substack.com